Agenus 2015 Annual Report 10-K

Agenus Inc. is a biopharmaceutical company focused on the development of cancer vaccines and immunotherapies. The company's portfolio includes proprietary platforms for generating therapeutic cancer vaccines and enhancing immune responses. This 2015 annual report details the company's business operations, intellectual property, regulatory compliance, and financial performance for the fiscal year ended December 31, 2015.